28
May 25
Online sale of drugs: recent trends in EU case law
The promotion and online sale of medicinal products are subject to a series of regulatory provisions and constraints.
28
May 25
Medical device payback: The Regional Administrative Court of Lazio rejects suppliers’ appeals
In a series of rulings issued in May 2025, the Regional Administrative Court of Lazio dismissed the appeals filed by medical device suppliers challenging the payback mechanism.
28
May 25
Drug advertising and commercial claims: the Regional Administrative Court of Lazio validates references to format-based savings
Public advertising that emphasizes the greater economic convenience of one over-the-counter drug format over another is considered lawful.
25
Feb 25
Procurement of biosimilar medicines in public tenders: Regulatory framework and recent caselaw
The procurement of biosimilars intended for the entities of the National Health Service, while generally regulated by the Public Procurement Code, is subject to special rules due to the unique characteristics of these products compared to chemically derived medicines.
25
Feb 25
Anti-counterfeiting of medicines: The new provisions of the Decree implementing delegated Regulation on falsified medicines
On February 6, 2025 the new Legislative Decree 10/2025 implementing the Delegated Regulation (EU) 2016/161 on the anti-counterfeiting of medicinal products was approved.
25
Feb 25
Supplementing rules to the Public Procurement Code: The new Decree and its impact on tenders and contracts
The new Legislative Decree 209/2024 introduces complementary and corrective provisions to the Italian Public Procurement Code with the aim of simplifying the current legislation and solving the problems that have arisen in the application of the new provisions of the Code, as also requested by the European Union.
